How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Genealogical DNA Test Market
- By Test Type: Autosomal DNA Test, Y-DNA Test, Mitochondrial DNA Test
- By Application: Ancestry and Ethnicity Determination, Health and Genetic Trait Analysis, Paternal Lineage Testing, Maternal Lineage Testing, Adoption and Family Reunion
- By End User: Individual Consumers, Research Institutions, Healthcare Providers, Legal and Forensic Agencies
- By Sample Type: Saliva Sample, Buccal Swab, Blood Sample
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Autosomal DNA Test leads By Test Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 10 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 258 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.162 →
- 11 Company Profiles 10 players: SWOT & benchmarking p.170 →
Full report · locked preview
Everything inside the Genealogical DNA Test Market report
A complete, evidence-based study - 11 chapters and 108 sections covering market size, segmentation across 4 axes, regional analysis and 10 company profiles, forecast to 2033.
Segmentation covered
Test Type 3
Application 5
End User 4
Sample Type 3
Companies profiled
AncestryDNA (Ancestry.com)
23andMe
MyHeritage DNA
FamilyTreeDNA
Living DNA
Nebula Genomics
Vitagene
Gene by Gene
TellmeGen
African Ancestry
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
10 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →AncestryDNA (Ancestry.com)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →23andMe
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →MyHeritage DNA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →FamilyTreeDNA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Living DNA
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.178 →Nebula Genomics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Vitagene
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Gene by Gene
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →TellmeGen
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.202 →African Ancestry
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,281M by 2033 · 8.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Autosomal DNA Test76.5
- Y-DNA Test11.7
- Mitochondrial DNA Test11.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,109M → $1,870M · 6.7%
Europe$773.3M → $1,379M · 7.5%
Asia Pacific$706.0M → $1,311M · 8.0%
Latin America$437.1M → $884.0M · 9.2%
Middle East and Africa$336.2M → $645.6M · 8.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.082026
8.082027
8.092028
8.112029
8.122030
8.132031
8.152032
8.162033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- AncestryDNA (Ancestry.com)19.9
- 23andMe20.1
- MyHeritage DNA7.4
- FamilyTreeDNA9.1
- Living DNA11.3
- Nebula Genomics4.1
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Test Type22.2%
Application27.5%
End User27.6%
Sample Type22.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.7
- Europe22.6
- Asia Pacific21.5
- Latin America14.5
- Middle East and Africa10.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| AncestryDNA (Ancestry.com) | 78 | 76 | 95 | 91 | 87 | 83 | 85 |
| 23andMe | 91 | 76 | 74 | 69 | 87 | 85 | 80 |
| MyHeritage DNA | 88 | 83 | 82 | 77 | 74 | 86 | 82 |
| FamilyTreeDNA | 73 | 64 | 66 | 82 | 62 | 65 | 69 |
| Living DNA | 73 | 71 | 61 | 64 | 53 | 52 | 62 |
| Nebula Genomics | 53 | 57 | 48 | 47 | 65 | 63 | 56 |
| Vitagene | 42 | 57 | 54 | 49 | 62 | 44 | 51 |
| Gene by Gene | 41 | 38 | 36 | 58 | 52 | 45 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- AncestryDNA (Ancestry.com)
- 23andMe
- MyHeritage DNA
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| AncestryDNA (Ancestry.com) | ✓ | ◐ | ◐ | ✓ | ✓ | ✓ |
| 23andMe | ◐ | ✓ | ✓ | ◐ | ✓ | ◐ |
| MyHeritage DNA | ✓ | ✓ | ◐ | ◐ | ✓ | ✓ |
| FamilyTreeDNA | ◐ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Living DNA | ◐ | − | ◐ | ◐ | − | ◐ |
| Nebula Genomics | ◐ | ◐ | − | − | − | ◐ |
| Vitagene | − | − | − | − | ◐ | − |
| Gene by Gene | ◐ | ◐ | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1AncestryDNA (Ancestry.com)85
2MyHeritage DNA82
323andMe80
4FamilyTreeDNA69
5Living DNA62
6Nebula Genomics56
7Vitagene51
8Gene by Gene45
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
AncestryDNA (Ancestry.com)23andMeMyHeritage DNA
Challenger1
Strong scale, closing on the leaders.
FamilyTreeDNA
Contender1
Focused players with pockets of strength.
Living DNA
Niche3
Specialists in a single segment or region.
Nebula GenomicsVitageneGene by Gene
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Test Type in North America, then scale across Genealogical DNA Test Market — a $278M beachhead inside a $4.16B market.
Beachhead (SOM)$278Mobtainable near-term
Serviceable (SAM)$1.68Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Autosomal DNA Test
Best fit — highest urgency & budget in Test Type.
Economic buyer78 fit
Y-DNA Test
Strong fit — clear ROI and a fast path to value.
End user66 fit
Mitochondrial DNA Test
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Test Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel29%
Digital / self-serve20%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Test Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Genealogical DNA Test Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified21%
Evaluation15%
Closed-won6%
$18.3KCAC
$66KLTV
3.6:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Genealogical DNA Test Market is a durable-growth opportunity — $6.63B by 2033, compounding at 6.7%.
TAM · 2025$3.95Btoday
TAM · 2033$6.63Bforecast
CAGR6.7%2027–2033
Cumulative$46.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.63BTotal addressable market
SAM$2.75BServiceable available market
SOM$489MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.7% CAGR
Demand compounds through 2033, outpacing GDP across Test Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Test Type moving from early to mainstream — durable secular demand.
Consolidation upside
10+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.63BLarge & growingTAM by 2033 at 6.7% CAGR
$2.75BServiceable nowreachable with today’s model
$489MBeachhead winobtainable near-term share
10+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.17BBear4.3% CAGR
$6.63BBase6.7% CAGR
$8.48BBull8.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Genealogical DNA Test Market — a $6.63B market by 2033. Plan: grow share from 9.0% to 13.9%.
Market size · 2033$6.63Btotal addressable
Market CAGR6.1%2027–2033
Target share13.9%from 9.0% today
Revenue ambition$921Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.0% | 13.9% | Ahead |
| Revenue | $643M | $921M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 28.6% | 43.7% | Ahead |
| Customer retention | 88.6% | 95.6% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Test Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Test Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $111M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Test Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Genealogical DNA Test Market conversation — a $6.28B market you can size, segment and defend in minutes.
Market size · 2033$6.28Btotal opportunity
Growth9.5%CAGR to 2033
Addressable buyers1,317+accounts in scope
Typical ROI6.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Test Type
Goal Grow share in Test Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.3×return on cost, year one
< 3 mopayback period
$64K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
10+players profiled in this market
Coverage includes
AncestryDNA (Ancestry.com)23andMeMyHeritage DNAFamilyTreeDNALiving DNANebula GenomicsVitageneGene by Gene+2 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Genealogical DNA Test Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Genealogical DNA Test Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Padlock Set Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportGem Refractometers Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportIn-Line Process Viscometer (ILPV) Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportGemological Microscopes Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportGem Microscope Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportGem Inspection Microscope Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportGemin 3 Monoclonal Antibody Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportGemin 3 Antibody Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportGemigliptin Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportGemigliptin L-tartrate sesquihydrate Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportGemifioxacin Mesylate Market
Market size, share, segmentation and regional forecast.
$749M market · 2025 base year
View reportGemcitabine Powder For Injection Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.